BSE filing, NSE: NOVARTIND. Summary written from the filing by ALFA Finder's alert engine.
Novartis India Ltd: key numbers
- Share price
- ₹1,711.90
- Market cap
- ₹4,227 Cr
- Revenue (annual)
- ₹354.3 Cr
- Net profit (annual)
- ₹93.18 Cr
- P/E (TTM)
- 43.2×Sector 45.9×
- Promoter holding
- 70.68%+0.00% QoQ
- FII holding
- 1.21%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Novartis India Ltd
All →Novartis India Board Meeting Date
Evonile Pharma will hold a board meeting on November 4, 2026 to approve the rights issue letter of offer. BSE granted in-principle approval for the rights issue.
Novartis India Management Change
Evonile Pharma (formerly Novartis India) appointed Mr. Gagan Sharma as President – Specialty Business and Senior Management Personnel effective October 26, 2026. The filing is a Regulation 30 senior management appointment intimation.
Novartis India Other Announcement
Novartis India Ltd has filed its quarterly shareholding pattern for the period ended September 30, 2026, as required under SEBI regulations. This is a routine periodic disclosure.
Novartis India Annual General Meeting
Evonile Pharma (fka Novartis India) issued a postal ballot notice for shareholder votes on ESOP 2026 grant to the MD & CEO and creation of charge on assets. E-voting runs 14 Oct–12 Nov 2026.
Novartis India Fund Raise of ₹900 Cr
Evonile Pharma Limited approved a rights issue to raise up to ₹900 Crore. The company also formed a committee to manage the issuance terms.
- Value
- ₹900.0 Cr
Novartis India Credit Rating
Evonile Pharma Limited has received credit ratings from CARE Ratings Limited for its bank facilities. The company disclosed the ratings as part of its regulatory filings.
Other merger & restructuring announcements
All →Viyash Scientific Merger & Restructuring Worth ₹3.8 Cr
Viyash's step-down subsidiary Alivira Vietnam was incorporated on 30 October 2026, with investment up to USD 400,000. It will distribute animal health products and APIs in Vietnam.
- Value
- ₹3.80 Cr
BirlaNu Merger & Restructuring Worth ₹0.15 Cr
BirlaNu's board approved subscribing to 1,50,000 shares of a proposed wholly-owned digital platform subsidiary at Rs.10 each. The cash consideration is Rs.0.15 Crore, with the entity yet to be incorporated.
- Value
- ₹0.15 Cr
Cressanda Railway Solutions Merger & Restructuring
Cressanda Railway's board reports a buyer has been found for subsidiary Cressanda Consumers, with a share purchase agreement to follow. No deal value is disclosed.
Harig Crankshafts Merger & Restructuring Worth ₹65 Cr
Harig Crankshafts agreed to sell its Noida Phase-II property for Rs 65 Crore to Sahu International Attire. Completion is expected by December 30, 2026.
- Value
- ₹65.00 Cr
UCAL Merger & Restructuring Worth ₹45 Cr
UCAL's subsidiary UPIL agreed to sell a 6.97-acre residential plot to promoter-group Sujo Land, receiving a Rs.45 Crore advance. Completion is expected by June 2027.
- Value
- ₹45.00 Cr
- Execution
- Completion tentatively before end of June 2027, subject to Mahindra Integrated Township approval
Shera Energy Merger & Restructuring Worth ₹47.5 Cr
Shera Energy's board approved a Dubai wholly-owned subsidiary for non-ferrous metals trading, with investment up to ₹47.5 Crore. This expands the company's international trading footprint.
- Value
- ₹47.50 Cr